Phathom Depreciation vs Sale Purchase Of Stock Analysis

PHAT Stock  USD 8.93  0.36  3.88%   
Phathom Pharmaceuticals financial indicator trend analysis is much more than just breaking down Phathom Pharmaceuticals prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Phathom Pharmaceuticals is a good investment. Please check the relationship between Phathom Pharmaceuticals Depreciation and its Sale Purchase Of Stock accounts. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Phathom Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.
For more information on how to buy Phathom Stock please use our How to Invest in Phathom Pharmaceuticals guide.

Depreciation vs Sale Purchase Of Stock

Depreciation vs Sale Purchase Of Stock Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Phathom Pharmaceuticals Depreciation account and Sale Purchase Of Stock. At this time, the significance of the direction appears to have weak contrarian relationship.
The correlation between Phathom Pharmaceuticals' Depreciation and Sale Purchase Of Stock is -0.17. Overlapping area represents the amount of variation of Depreciation that can explain the historical movement of Sale Purchase Of Stock in the same time period over historical financial statements of Phathom Pharmaceuticals, assuming nothing else is changed. The correlation between historical values of Phathom Pharmaceuticals' Depreciation and Sale Purchase Of Stock is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Depreciation of Phathom Pharmaceuticals are associated (or correlated) with its Sale Purchase Of Stock. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Sale Purchase Of Stock has no effect on the direction of Depreciation i.e., Phathom Pharmaceuticals' Depreciation and Sale Purchase Of Stock go up and down completely randomly.

Correlation Coefficient

-0.17
Relationship DirectionNegative 
Relationship StrengthInsignificant

Depreciation

Depreciation indicates how much of Phathom Pharmaceuticals value has been used up. For tax purposes Phathom Pharmaceuticals can deduct the cost of the tangible assets it purchases as business expenses. However, Phathom Pharmaceuticals must depreciate these assets in accordance with IRS rules about how and when the deduction may be taken, and how long it will last. The systematic allocation of the cost of a tangible asset over its useful life.

Sale Purchase Of Stock

Most indicators from Phathom Pharmaceuticals' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Phathom Pharmaceuticals current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Phathom Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.
For more information on how to buy Phathom Stock please use our How to Invest in Phathom Pharmaceuticals guide.Selling General Administrative is likely to gain to about 123.8 M in 2024, whereas Issuance Of Capital Stock is likely to drop slightly above 84.4 M in 2024.
 2021 2022 2023 2024 (projected)
Reconciled Depreciation521K620K575K450.3K
Cost Of Revenue521K620K167K158.7K

Phathom Pharmaceuticals fundamental ratios Correlations

0.850.60.830.250.260.86-0.95-0.870.841.01.00.940.940.950.960.770.740.941.01.00.070.760.830.590.77
0.850.550.76-0.17-0.160.93-0.69-0.950.80.850.850.970.910.850.940.850.40.870.850.84-0.130.980.910.40.98
0.60.550.910.270.280.77-0.59-0.570.890.620.620.640.690.510.650.410.590.640.610.550.680.560.790.940.44
0.830.760.910.150.160.88-0.78-0.770.990.840.840.830.820.720.830.670.580.780.830.790.510.720.920.90.68
0.25-0.170.270.151.0-0.03-0.360.180.090.260.260.010.220.20.12-0.380.80.310.260.270.43-0.26-0.120.37-0.35
0.26-0.160.280.161.0-0.02-0.380.170.10.280.280.030.230.220.14-0.360.810.320.280.290.42-0.24-0.110.37-0.34
0.860.930.770.88-0.03-0.02-0.78-0.960.90.870.870.960.930.840.940.850.550.870.860.840.10.920.970.630.88
-0.95-0.69-0.59-0.78-0.36-0.38-0.780.78-0.77-0.96-0.96-0.82-0.85-0.89-0.86-0.72-0.81-0.84-0.96-0.96-0.14-0.59-0.73-0.63-0.6
-0.87-0.95-0.57-0.770.180.17-0.960.78-0.8-0.86-0.86-0.96-0.9-0.89-0.94-0.94-0.44-0.84-0.86-0.860.14-0.93-0.93-0.44-0.94
0.840.80.890.990.090.10.9-0.77-0.80.840.840.860.840.750.850.70.540.80.830.790.460.760.950.870.72
1.00.850.620.840.260.280.87-0.96-0.860.841.00.930.940.950.960.760.750.941.01.00.090.760.830.610.76
1.00.850.620.840.260.280.87-0.96-0.860.841.00.930.940.950.960.760.750.941.01.00.090.760.830.610.76
0.940.970.640.830.010.030.96-0.82-0.960.860.930.930.970.930.990.840.580.950.930.92-0.020.940.930.530.92
0.940.910.690.820.220.230.93-0.85-0.90.840.940.940.970.950.990.720.730.990.940.930.050.860.880.580.82
0.950.850.510.720.20.220.84-0.89-0.890.750.950.950.930.950.960.750.70.960.950.96-0.10.770.80.460.77
0.960.940.650.830.120.140.94-0.86-0.940.850.960.960.990.990.960.80.660.970.960.95-0.010.890.910.550.87
0.770.850.410.67-0.38-0.360.85-0.72-0.940.70.760.760.840.720.750.80.240.640.760.75-0.210.820.840.340.88
0.740.40.590.580.80.810.55-0.81-0.440.540.750.750.580.730.70.660.240.760.750.750.290.310.430.590.24
0.940.870.640.780.310.320.87-0.84-0.840.80.940.940.950.990.960.970.640.760.940.940.050.810.820.550.76
1.00.850.610.830.260.280.86-0.96-0.860.831.01.00.930.940.950.960.760.750.941.00.080.760.830.60.76
1.00.840.550.790.270.290.84-0.96-0.860.791.01.00.920.930.960.950.750.750.941.00.020.740.790.540.75
0.07-0.130.680.510.430.420.1-0.140.140.460.090.09-0.020.05-0.1-0.01-0.210.290.050.080.02-0.140.20.82-0.24
0.760.980.560.72-0.26-0.240.92-0.59-0.930.760.760.760.940.860.770.890.820.310.810.760.74-0.140.90.370.98
0.830.910.790.92-0.12-0.110.97-0.73-0.930.950.830.830.930.880.80.910.840.430.820.830.790.20.90.70.87
0.590.40.940.90.370.370.63-0.63-0.440.870.610.610.530.580.460.550.340.590.550.60.540.820.370.70.28
0.770.980.440.68-0.35-0.340.88-0.6-0.940.720.760.760.920.820.770.870.880.240.760.760.75-0.240.980.870.28
Click cells to compare fundamentals

Phathom Pharmaceuticals Account Relationship Matchups

Phathom Pharmaceuticals fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets257.2M295.1M189.4M164.8M413.8M242.2M
Short Long Term Debt Total23.6M49.0M91.3M97.1M139.0M73.7M
Other Current Liab413K30.4M12.8M14.8M7.1M12.4M
Total Current Liabilities3.7M55.5M18.9M26.2M38.8M26.7M
Total Stockholder Equity228.0M194.3M72.2M(74.8M)(72.8M)(69.1M)
Net Tangible Assets228.0M194.3M72.2M(74.8M)(67.3M)(64.0M)
Net Debt(220.2M)(238.5M)(91.9M)(58.3M)(242.4M)(230.2M)
Retained Earnings(256.4M)(385.5M)(529.4M)(727.1M)(928.7M)(882.3M)
Accounts Payable699K16.8M5.2M10.0M12.6M8.3M
Cash243.8M287.5M183.3M155.4M381.4M229.6M
Non Current Assets Total1.6M3.7M2.9M4.3M16.4M17.2M
Non Currrent Assets Other181K384K341K299K9.9M10.4M
Cash And Short Term Investments243.8M287.5M183.3M155.4M381.4M229.6M
Common Stock Shares Outstanding24.7M33.2M37.0M39.1M51.3M35.6M
Liabilities And Stockholders Equity257.2M295.1M189.4M164.8M413.8M242.2M
Non Current Liabilities Total25.5M45.3M98.4M213.4M447.8M470.2M
Other Current Assets11.8M7.7M6.5M10.3M13.2M9.1M
Other Stockholder Equity484.4M579.8M601.5M652.3M855.9M581.9M
Total Liab29.2M100.8M117.3M239.6M486.6M510.9M
Net Invested Capital250.7M241.3M161.8M20.5M65.1M98.7M
Total Current Assets255.6M291.4M186.5M160.5M397.4M236.9M
Net Working Capital251.9M235.8M167.6M134.3M358.7M210.3M
Short Term Debt161K8.3M974K1.4M726K689.7K

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Phathom Stock Analysis

When running Phathom Pharmaceuticals' price analysis, check to measure Phathom Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Phathom Pharmaceuticals is operating at the current time. Most of Phathom Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Phathom Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Phathom Pharmaceuticals' price. Additionally, you may evaluate how the addition of Phathom Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.